Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03366272
Title Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients (NIVEAU)
Acronym NIVEAU
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Universität des Saarlandes
Age Groups: senior | adult
Covered Countries NLD | FRA | DEU | BEL | AUT

No variant requirements are available.